Seeking Alpha EN

Kamada GAAP EPS of $0.06 misses by $0.02, revenue of $44.68M misses by $1.94M

Mar 11, 2026 &03041111202631; 11:04 UTC seekingalpha.com Trending 2/5

Read original on seekingalpha.com ↗

↘

Negative for markets

Sentiment score: -65/100

Moderate impact Short-term (days)

WHAT THIS MEANS

Kamada reported Q3 GAAP EPS of $0.06, missing consensus estimates by $0.02, while revenue of $44.68M fell short of expectations by $1.94M. The dual miss indicates operational challenges and potential margin compression affecting the biopharmaceutical company's near-term profitability outlook.

AI CONFIDENCE

85% Very high

SENTIMENT GAUGE

NEWS POWER SCORE

AFFECTED ASSETS

↓

KAMADA

KAMADAStock

Expected to decline

Earnings miss on both EPS and revenue metrics signals weaker-than-expected operational performance and potential guidance concerns

PRICE HISTORY

Loading chart...

⚡ SUGGESTED ACTION

Consider reducing exposure to KAMADA on this earnings miss. Monitor upcoming guidance and management commentary for signs of demand weakness or cost pressures. Watch for technical support levels as the stock likely faces near-term selling pressure.

KEY SIGNALS

EPS miss of $0.02 (25% below consensus)Revenue miss of $1.94M (4.2% below expectations)Potential margin compressionOperational execution challenges

SECTORS INVOLVED

HealthcareBiopharmaceuticals

Analysis generated on Mar 11, 2026 at 11:30 UTC

Disclaimer: This analysis is generated by artificial intelligence for informational purposes only and does not constitute financial advice, investment recommendation, or solicitation. Original reporting by Seeking Alpha. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Kamada GAAP EPS of $0.06 misses by $0.02, revenue of $44.68M misses by $1.94M

RELATED INTELLIGENCE